Advanced Glycosylation End Products in Peritoneal Tissue with Different Solutions

Dobbie J.W. , Zaki M.A. , Wilson L.S. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 1981; 26: 213–23.

Dobbie J.W. , Zaki M.A. The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich, 1986; 3–10.

Dobbie J.W. Pathology of the peritoneum. In: Bengmark S. , ed. The Peritoneum, and Peritoneal Access. London: Wright, 1988; 42–52.

Dobbie J.W. Monitoring peritoneal histopathology in peritoneal dialysis: The role of a biopsy registry. Dial Transplant 1989; 18(6): 319–35.

Dobbie J.W. , Lloyd J.K. , Gall C.A. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , eds. Advances in Continuous Ambulatory Peritoneal Dialysis. Toronto: University of Toronto Press, 1990; 3–12.

Dobbie J.W. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. PeritDiallnt 1992; 12: 14–27.

Dobbie J.W. The peritoneal biopsy registry: a watchdog for peritoneal dialysis. Sem Dial 1992; 5(1): 20–3.

Mistry C.D. , Gokal R. , Peers E.M. , and the MIDAS study group. A randomized multicenter clinical trial comparing iso-osmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46: 496–503.

Maillard L.C. Action des acides aminés sur les sucres; formation des melanoidines par voie méthodique. CR Acad Sci 1912; 154: 66–8.

Pirie A. Color and solubility of the protein of human cataract. Invest Opthalmol 1968; 7: 634–50.

Trivelli R.A. , Ranney H.M. , Hont-Tien L. Hemoglobin components in patients with diabetes mellitus. NEngl J Med 1971; 284: 353–7.

Cerami A. , Stevens V.J. , Monnier V.M. Role of non-enzymatic glycosolation in the development of the sequelae of diabetes. Metabolism 1979; 28: 431–7.

Brownlee M. , Vlassara H. , Cerami A. Non-enzymatic glycosolation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527–37.

Vishwanath V. , Frank K.E. , Elmets C.A. Glycation of skin collagen in Type I diabetes mellitus: Role in the in situ formation of immune complexes. Diabetes 1986; 35: 916–21.

Monnier V.M. , Kohn R.R. , Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984; 81: 583–7.

Monnier V.M. , Vishwanath V. , Frank K.E. Relation between complications of Type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403–8.

Vlassara H. , Brownlee M. , Cerami A. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med 1986; 164: 1301–9.

Schmidt A.M. , Hori O. , Cao R. RAGE: Anovel cellular receptor for advanced glycation end products. Diabetes 1996; 45 S77–80.

Brownlee M. , Cerami A. , Vlassaria H. Advanced glycosolation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med, 1988; 318: 1315–21.

Wautier J.L. , Zoukourian C. , Chappey O. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products, blocks, hyperpermeability in diabetic rats. J Clin Invest 1996; 97: 238–43.

Brownlee M. , Vlassaria H. , Cerami A. Non-enzymatic glycosolation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527–37.

Gotloib L. , Bar Sella P. , Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: ultrastructural changes of reduplicated peritoneal basal membrane. Perit Dial Bull 1985; 5: 212–5.

Di Paolo N. , Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41–5.

Bitensky M.W. , Kowluru A. , Kowluru R.A. Non-enzymatic glycation and protein recognition. In: Baynes J.W. , Monnier V.M. , eds. The Maillard Reaction in Ageing Diabetes and Nutrition. New York: Alan R. Liss Inc. 1989; 185–203.

Lamb E. , Cattell W.R. , Dawnay A.B. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993; 84: 619–26.

Lamb E. , Cattell W.R. , Dawnay A.B. In vitro formation of advanced glycation end-products in peritoneal dialysis fluid. Kidney Int 1995; 47: 1768–74.

Friedlander M.A. , Wu Y.C. , Elgawish A. , Monnier V. Early and advanced glycosolation end-products. Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 1996; 97: 728–35.

Dawnay A.B. Advanced glycation end-products in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S50–3.

Dawnay A.B. , Millar D.J. Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int 1997; 17: 21–8.

Scallit B. , Gardner J.H. The formation of 5-hydroxymethyl-furfural from D-glucose in aqueous solutions. J Amer Chem Soc 1945; 67: 1934–5.

Singh B. , Dean G.R. , Cantor S.M. The role of 5–(hydroxymethyl)-furfural in the discoloration of sugar solutions. JAmer Chem Soc 1948; 70: 517–22.

Dobbie J.W. Serositis: Comparative analysis of histological findings and pathogenetic mechanisms in nonbacterial serosal inflammation. Perit Dial Int 1993; 13: 256–9.